HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (48) Citing Articles via Google Scholar Google Scholar Articles by HAGBERG, J. M. Articles by FERRELL, R. E. Search for Related Content PubMed PubMed Citation Articles by HAGBERG, J. M. Articles by FERRELL, R. E.

Review

APO E gene and gene-environment effects on plasma lipoprotein-lipid levels

Department of Kinesiology, University of Maryland, College Park, Maryland 20742-2611; and Department of Human Genetics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania 15260

Apolipoprotein E (apo E) is important in plasma lipid metabolism and is a component of several plasma lipoprotein-lipid particles. Three major apo E isoforms are encoded by three common alleles at the APO E locus. The E2 allele is associated with lower and the E4 allele with higher total plasma cholesterol and LDL cholesterol levels compared with the E3 allele. Available data generally indicate that APO E2, and possibly E3, genotype individuals reduce plasma total and low-density lipoprotein (LDL) cholesterol levels more than APO E4 individuals with statin therapy. Some evidence also indicates that APO E2 individuals are more likely to respond favorably to gemfibrozil and cholestyramine. On the other hand, it appears that with probucol, APO E4 genotype individuals may improve plasma lipoprotein-lipid profiles more than APO E3 individuals. APO E2 and E3 genotype perimenopausal women appear to improve plasma lipoprotein-lipid profiles more with hormone replacement therapy than APO E4 women. On the other hand, low-fat diet interventions tend to reduce plasma LDL cholesterol and, perhaps, plasma total cholesterol levels more in APO E4 than in APO E2 or E3 individuals. Both cross-sectional and longitudinal studies generally indicate that APO E2 and E3 individuals improve plasma lipoprotein-lipid profiles more with exercise training than APO E4 individuals. Although these data are hardly definitive, they lend strong support for the possibility that in the near future individuals will be directed to what might be their optimal therapy for improving plasma lipoprotein-lipid profiles and cardiovascular disease risk based partially on APO E genotype.

apolipoprotein E; dyslipidemia; diet; exercise training

This article has been cited by other articles:

				M. L. Masemola, M. Alberts, and P. Urdal Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population 1 Scand J Public Health, August 1, 2007; 35(69_suppl): 60 - 65. [Abstract] [PDF]

				K. L.E. Klos, C. F. Sing, E. Boerwinkle, S. C. Hamon, T. J. Rea, A. Clark, M. Fornage, and J. E. Hixson Consistent Effects of Genes Involved in Reverse Cholesterol Transport on Plasma Lipid and Apolipoprotein Levels in CARDIA Participants Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1828 - 1836. [Abstract] [Full Text] [PDF]

				Y. Song, M. J. Stampfer, and S. Liu Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease Ann Intern Med, July 20, 2004; 141(2): 137 - 147. [Abstract] [Full Text] [PDF]

				S. C. Smith Jr, R. V. Milani, D. K. Arnett, J. R. Crouse III, M. M. McDermott, P. M Ridker, R. S. Rosenson, K. A. Taubert, and P. W.F. Wilson Atherosclerotic Vascular Disease Conference: Writing Group II: Risk Factors Circulation, June 1, 2004; 109(21): 2613 - 2616. [Full Text] [PDF]

				Y. Bosse, Y. C. Chagnon, J-P. Despres, T. Rice, D. C. Rao, C. Bouchard, L. Perusse, and M-C. Vohl Genome-wide linkage scan reveals multiple susceptibility loci influencing lipid and lipoprotein levels in the Quebec Family Study J. Lipid Res., March 1, 2004; 45(3): 419 - 426. [Abstract] [Full Text] [PDF]

				A. C.M. Bonne, M. G. den Bieman, G. F. Gillissen, A. Lankhorst, C. J. Kenyon, B. F.M. van Zutphen, and H. A. van Lith Quantitative Trait Loci Influencing Blood and Liver Cholesterol Concentration in Rats Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 2072 - 2079. [Abstract] [Full Text] [PDF]

				H. Knoblauch, A. Bauerfeind, C. Krahenbuhl, A. Daury, K. Rohde, S. Bejanin, L. Essioux, H. Schuster, F. C. Luft, and J. Georg Reich Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population Hum. Mol. Genet., June 1, 2002; 11(12): 1477 - 1485. [Abstract] [Full Text] [PDF]

				M. S. Bernstein, M. C. Costanza, R. W. James, M. A. Morris, F. Cambien, S. Raoux, and A. Morabia Physical Activity May Modulate Effects of ApoE Genotype on Lipid Profile Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 133 - 140. [Abstract] [Full Text] [PDF]

				T. Rice, J.-P. Despres, L. Perusse, Y. Hong, M. A. Province, J. Bergeron, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, et al. Familial Aggregation of Blood Lipid Response to Exercise Training in the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study Circulation, April 23, 2002; 105(16): 1904 - 1908. [Abstract] [Full Text] [PDF]